China Isotope & Radiation Past Earnings Performance
Past criteria checks 1/6
China Isotope & Radiation has been growing earnings at an average annual rate of 7.9%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 13.6% per year. China Isotope & Radiation's return on equity is 10.9%, and it has net margins of 6%.
Key information
7.9%
Earnings growth rate
7.9%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 13.6% |
| Return on equity | 10.9% |
| Net Margin | 6.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
China Isotope & Radiation Corporation's (HKG:1763) 36% Share Price Surge Not Quite Adding Up
Oct 07
China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think
May 05Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price
Apr 26China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet
Mar 28There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
May 13Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Feb 07China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends
Dec 20A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)
Oct 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Sep 30There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
Aug 30Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?
Jun 10China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt
Apr 11Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?
Dec 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Oct 26Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal
Oct 08Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?
Sep 05Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture
Jun 13When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?
May 24China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet
Apr 01Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)
Mar 14The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More
Feb 04
Revenue & Expenses Breakdown
How China Isotope & Radiation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 6,706 | 400 | 2,405 | 282 |
| 31 Mar 24 | 6,670 | 386 | 2,441 | 294 |
| 31 Dec 23 | 6,635 | 371 | 2,477 | 306 |
| 30 Sep 23 | 6,454 | 388 | 2,393 | 313 |
| 30 Jun 23 | 6,273 | 406 | 2,308 | 319 |
| 31 Mar 23 | 6,214 | 399 | 2,352 | 310 |
| 31 Dec 22 | 6,154 | 392 | 2,396 | 301 |
| 30 Sep 22 | 5,929 | 367 | 2,430 | 267 |
| 30 Jun 22 | 5,705 | 341 | 2,463 | 233 |
| 31 Mar 22 | 5,425 | 338 | 2,397 | 214 |
| 31 Dec 21 | 5,144 | 336 | 2,331 | 196 |
| 30 Sep 21 | 4,979 | 292 | 2,289 | 192 |
| 30 Jun 21 | 4,815 | 248 | 2,247 | 188 |
| 31 Mar 21 | 4,544 | 231 | 2,083 | 170 |
| 31 Dec 20 | 4,274 | 214 | 1,918 | 153 |
| 30 Sep 20 | 4,063 | 233 | 1,943 | 99 |
| 30 Jun 20 | 3,851 | 253 | 1,967 | 45 |
| 31 Mar 20 | 3,920 | 291 | 2,073 | 22 |
| 31 Dec 19 | 3,989 | 329 | 2,179 | 0 |
| 30 Sep 19 | 3,760 | 341 | 2,036 | 0 |
| 30 Jun 19 | 3,531 | 352 | 1,894 | 0 |
| 31 Mar 19 | 3,390 | 337 | 1,804 | 0 |
| 31 Dec 18 | 3,250 | 322 | 1,715 | 0 |
| 30 Sep 18 | 3,085 | 308 | 1,617 | 0 |
| 30 Jun 18 | 2,920 | 294 | 1,519 | 0 |
| 31 Mar 18 | 2,796 | 283 | 1,456 | 0 |
| 31 Dec 17 | 2,672 | 271 | 1,392 | 0 |
| 31 Dec 16 | 2,363 | 262 | 1,192 | 0 |
| 31 Dec 15 | 2,152 | 254 | 1,045 | 0 |
Quality Earnings: 1763 has a high level of non-cash earnings.
Growing Profit Margin: 1763's current net profit margins (6%) are lower than last year (6.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1763's earnings have grown by 7.9% per year over the past 5 years.
Accelerating Growth: 1763's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1763 had negative earnings growth (-1.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-4.3%).
Return on Equity
High ROE: 1763's Return on Equity (10.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 12:28 |
| End of Day Share Price | 2025/01/28 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Isotope & Radiation Corporation is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| null null | CLSA |
| Bo Li | CLSA |